Blockade of IL-33/ST2 ameliorates airway inflammation in a murine model of allergic asthma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Blockade of IL-33/ST2 ameliorates airway inflammation in a murine model of allergic asthma

Published:2014-01-21 Issue:2 Volume:40 Page:66-76
ISSN:0190-2148
Container-title:Experimental Lung Research
language:en
Short-container-title:Experimental Lung Research

Author:

Lee Hea Yon,Rhee Chin Kook,Kang Ji Young,Byun Ji Hae,Choi Joon Young,Kim Seung Joon,Kim Young Kyoon,Kwon Soon Suk,Lee Sook Young

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Pulmonary and Respiratory Medicine,Molecular Biology

Link

http://www.tandfonline.com/doi/pdf/10.3109/01902148.2013.870261

Reference38 articles.

1. IL-13 induces eosinophil recruitment into the lung by an IL-5– and eotaxin-dependent mechanism

2. Interleukin-4-dependent pulmonary eosinophil infiltration in a murine model of asthma.

3. IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated Cytokines

4. IL-33 Induces Antigen-Specific IL-5+ T Cells and Promotes Allergic-Induced Airway Inflammation Independent of IL-4

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Difamilast, a Topical Phosphodiesterase 4 Inhibitor, Produces Soluble ST2 via the AHR–NRF2 Axis in Human Keratinocytes;International Journal of Molecular Sciences;2024-07-19

2. Tollip deficiency exaggerates airway type 2 inflammation in mice exposed to allergen and influenza A virus: role of the ATP/IL-33 signaling axis;Frontiers in Immunology;2023-12-06

3. Strategies targeting IL-33/ST2 axis in the treatment of allergic diseases;Biochemical Pharmacology;2023-12

4. IL-33-induced neutrophilic inflammation and NETosis underlie rhinovirus-triggered exacerbations of asthma;Mucosal Immunology;2023-10

5. TRAF4 is crucial for ST2+ memory Th2 cell expansion in IL-33–driven airway inflammation;JCI Insight;2023-09-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3